Jonae Barnes
Senior Vice President of Investor Relations and Corporate Communications
Replay available
Atea Pharmaceuticals, Inc. (AVIR) Q2 2026 Earnings Call
Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) Q2 2026 earnings conference call, held 2026-08-12. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Jean-Pierre Sommadossi
Chief Executive Officer and Founder
Dr. Arantxa Horga
Chief Medical Officer
Dr. Janet Hammond
Chief Development Officer
John Vavricka
Chief Commercial Officer
Andrea Corcoran
Chief Financial Officer and Executive Vice President of Legal
Andy Shea
Analyst, William Blair
Jonathan Miller
Analyst, Evercore ISI
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Atea Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a04117-addc-7061-afd7-a9002b9ccdc5 Created: 2026-08-27T02:41:08.319Z Duration: 2425.7307 Channels: 1 00:00:00.000 -- 00:00:02.480 Good afternoon, everyone, and welcome to the Atea 00:00:02.480 -- 00:00:03.600 Pharmaceuticals 00:00:03.600 -- 00:00:07.120 second quarter twenty twenty six financial results and 00:00:07.120 -- 00:00:08.959 business update conference call. 00:00:09.200 -- 00:00:11.280 At this time, all participants are in a 00:00:11.280 -- 00:00:14.445 listen only mode. Following the formal remarks, we 00:00:14.445 -- 00:00:16.285 will open the call up for your questions. 00:00:16.685 -- 00:00:18.285 I would now like to turn the call 00:00:18.285 -- 00:00:21.165 over to Jonay Barnes, senior vice president of 00:00:21.165 -- 00:00:23.884 investor relations and corporate communications 00:00:23.965 -- 00:00:25.724 at Atea Pharmaceuticals. 00:00:25.884 -- 00:00:27.165 Miss Barnes, please proceed. 00:00:28.330 -- 00:00:31.450 Thank you, operator. Good afternoon, everyone, and welcome 00:00:31.450 -- 00:00:34.570 to Atea Pharmaceuticals second quarter twenty twenty six 00:00:34.570 -- 00:00:37.850 financial results and business update conference call. Earlier 00:00:37.850 -- 00:00:41.210 today, we issued a press release which outlines 00:00:40.605 -- 00:00:42.925 the topics we plan to discuss. You can 00:00:42.925 -- 00:00:44.684 access the press release as well as the 00:00:44.684 -- 00:00:47.004 slides that we'll be reviewing today by going 00:00:47.004 -- 00:00:49.245 to the Investors section of our website at 00:00:49.245 -- 00:00:51.644 ir.ateapharma.com. 00:00:51.885 -- 00:00:54.750 With me from Atea are chief executive officer 00:00:54.750 -- 00:00:57.470 and founder, doctor Jean Pierre Samado...